Spanish HIV Clinical Forum – Madrid

Bienvenido al / Welcome to

the Spanish HIV Clinical Forum meeting website!

Spanish HIV Forum_18_19_ Madrid -164 smallThe Spanish HIV Clinical Forum in Madrid on 18 and 19 November turned out to be a big success. Thank you to all our participants! We are overwhelmed with the positive feedback and remarks. To all who were unable to join us this year, we hope to see you next year!

The meeting included lively discussions and exciting lectures, giving the participants the opportunity to discuss and meet with the experts in the field.

If you would like to (re)view the presentation materials, please visit our InfectiousDiseasesOnline website and click on the meeting. The webcasts will follow soon.

We invite you to join our mailing list to stay informed on next year’s meeting. Please let us know if you would like to be added to this mailinglist. We would like to encourage you and your colleagues to plan submission of your research results to one of our  2017 Forum meetings. The next HIV Clinical Forum: Integrase Inhibitors in Europe will be held on 22 July 2017, just prior to the IAS 2017 in Paris, France.

We would like to thank our conference supporters and endorsers for their support: ViiV Healthcare for the unrestricted educational grant and Siemens Healthineers for its contribution. We also like to thank GeSIDA, SEIMC, IAPAC, ESAR and EATG for their endorsement.

We look forward to welcoming you again at the next HIV Clinical Forum meeting!

Presentaciones por expertos de opinión clave nacionales en español y internacionales en inglés.
P&R y clinical cases en español.

Presentatión de resúmenes en español o inglés

Program – Day 1

14.00h - Opening & Welcome

Chairs: José Arribas, José Ramón Blanco and Antonio Antela

Charles Boucher, MD, PhD

14.15h – 14.45h
Basic Science of Integrase Inhibitors

Charles Boucher, PhD, MD
Erasmus Medical Center, Rotterdam, The Netherlands


Jonathan Schapiro, MD

14.45h- 15.15h
Resistance characteristics of Integrase inhibitors

Jonathan Schapiro, MD
Sheba Medical Center, Ramat Gan, Israel

15.15h - 15.45h - DISCUSSION

15.45h - 16.15h - COFFEE BREAK

Chairs: Jonathan Schapiro, Pere Domingo and Vicente Estrada

David Back, PhD

16.15h – 16.45h
Pharmacological considerations in Optimal Integrase Inhibitor Clinical Care

David Back, PhD
University of Liverpool, UK

16.45h - 17.00h - DISCUSSION

José Arribas, MD

17.00h – 17.30h
Reduced Drug Regimens

José Arribas, MD
La Paz University Hospital, Madrid, Spain

Ignacio Pérez Valero, MD

17.30h – 18.00h
Clinical Case Discussion

Ignacio Pérez-Valero, MD, PhD
La Paz University Hospital, Madrid, Spain

18.00h - 18.30 - DRINKS

18.30h - 19.30h - ABSTRACTS & DATA PRESENTATIONS

Chairs: Dolores Merino and Joaquín Portilla
18:30h Eficacia y tolerabilidad de los regímenes terapéuticos con dolutegravir en la práctica clínica habitual    Lucia Miguel-Escuder

18:45h Occurrence of INSTIs resistance mutation among HIV-1 patients     Raquel Téllez

19:00h Cambio a un regimen antirretroviral (Arg) con Dolutegravir (DTG) en el tratamiento  del vhc con Antivirales de acción directa (AAD) en pacientes coinfectados      Lucio Jesús Garcia-Fraile

19.30h - END PROGRAM DAY 1

Program – Day 2

Chairs: Charles Boucher and Frederico Pulido

Andrew Hill, PhD

9.30h – 10.00h
Designing Clinical trials: Highlights and Tips

Andrew Hill, PhD
University of Liverpool, United Kingdom

10.00h - 10.15h - DISCUSSION

Julia Del Amo, MD, PhD

10.15h – 10.45h
Retos y errores en el análisis de las bases de datos clínicos procedentes de estudios observacionales

Julia Del Amo, MD, PhD
Instituto de Salud Carlos III, Madrid, Spain

10.45h - 11.00h - DISCUSSION

11.00h - 11.30h - COFFEE BREAK

11.30h – 12.30h
Clinical Case Discussions

12.30h - CLOSURE by Workshop Chairs

Program Chairs

Charles Boucher, MD, PhD

Charles Boucher, MD, PhD
Erasmus Medical Centre Rotterdam, The Netherlands

Jonathan Schapiro, MD

Jonathan Schapiro, MD
Sheba Medical Center, Israel

José Arribas, MD

José Arribas, MD
La Paz University Hospital, Spain

Invited Scientific Committee

Antonio Antela López
Hospital Clínico Universitario CHOU, Santiago de Compostela, Spain

Juan Berenguer
Hospital Gregorio Marañón, Madrid, Spain

José Ramón Blanco
Hospital San Pedro, Logroño, Spain

Marta Boffito
Chelsea & Westminster Hospital, London, United Kingdom

Julia Del Amo
Instituto de Salud Carlos III, Madrid, Spain

Pere Domingo
Hospital Santa María, Lleida, Spain


Vicente Estrada
Hospital Clínico San Carlos, Madrid, Spain

Andrew Hill
University of Liverpool, United Kingdom

Esteban Martinez
Hospital Clinic de Barcelona, Barcelona, Spain

Dolores Merino Muñoz
Hospital Infanta Elena, Huelva, Spain

Celia Miralles
Hospital Xeral de Vigo, Pontevedra, Spain

Santiago Moreno
Hospital Ramon y Cajal, Madrid, Spain

José A. Pérez Molina
Hospital Ramon y Cajal, Madrid, Spain

Ignacio Pérez-Valero
Hospital La Paz, Madrid, Spain

Joaquín Portilla
Hospital General Universitari d’Alacant, Alacant, Spain

Federico Pulido
Hospital 12 de Octubre, Madrid, Spain

Esteban Ribera
Hospital General Vall d´Hebron, Barcelona, Spain

Antonio Rivero Román
Hospital Reina Sofía, Córdoba, Spain

The Spanish HIV Clinical Forum Meeting in Madrid was supported by an unrestricted educational grant from:

ViiVHealthcare

 

Contributor

Siemens Healthineers Logo Web

Endorsers

This meeting was endorsed by:

If you are interested in endorsing this meeting, please do not hesitate to contact Ms. Jo-Els van der Woude at jo-els@vironet.com for more information.

Accreditation

UEMS_logo

The Spanish HIV Clinical Forum: Integrase Inhibitors has been granted 6 European CME credits (ECMEC) by the European Accreditation Council for Continuing Medical Education (EACCME).

CONTACT US

We're not around right now. Please send us an email and we'll get back to you, asap.

Sending

©2017 Virology Education

Log in with your credentials

or    

Forgot your details?